Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Methicillin-Resistant Staphylococcus aureus | 55 | 2022 | 698 | 10.620 |
Why?
|
Cross Infection | 61 | 2022 | 1422 | 10.000 |
Why?
|
Staphylococcal Infections | 59 | 2019 | 1408 | 9.020 |
Why?
|
Carrier State | 43 | 2020 | 523 | 6.570 |
Why?
|
Infection Control | 36 | 2020 | 981 | 5.170 |
Why?
|
Chlorhexidine | 12 | 2019 | 160 | 3.710 |
Why?
|
California | 43 | 2019 | 1429 | 3.300 |
Why?
|
Nursing Homes | 18 | 2020 | 1082 | 3.010 |
Why?
|
Disinfection | 9 | 2019 | 211 | 2.880 |
Why?
|
Hospitals | 29 | 2022 | 3882 | 2.860 |
Why?
|
Mupirocin | 8 | 2019 | 55 | 2.240 |
Why?
|
Surgical Wound Infection | 16 | 2022 | 1527 | 2.060 |
Why?
|
Methicillin Resistance | 12 | 2011 | 198 | 2.010 |
Why?
|
Bacteremia | 14 | 2022 | 979 | 1.950 |
Why?
|
Enterobacteriaceae Infections | 7 | 2020 | 188 | 1.950 |
Why?
|
Intensive Care Units | 24 | 2019 | 3745 | 1.870 |
Why?
|
Catheter-Related Infections | 7 | 2022 | 273 | 1.860 |
Why?
|
Drug Resistance, Multiple, Bacterial | 11 | 2020 | 587 | 1.830 |
Why?
|
Enterococcus | 11 | 2013 | 159 | 1.760 |
Why?
|
Pneumococcal Infections | 15 | 2017 | 501 | 1.740 |
Why?
|
Disinfectants | 5 | 2019 | 130 | 1.560 |
Why?
|
Vancomycin Resistance | 10 | 2013 | 125 | 1.500 |
Why?
|
Staphylococcus aureus | 15 | 2019 | 1458 | 1.460 |
Why?
|
Drug Resistance, Bacterial | 11 | 2016 | 1048 | 1.380 |
Why?
|
Disease Outbreaks | 12 | 2020 | 1749 | 1.320 |
Why?
|
Streptococcus pneumoniae | 14 | 2017 | 730 | 1.260 |
Why?
|
Anti-Infective Agents, Local | 5 | 2019 | 247 | 1.250 |
Why?
|
Baths | 4 | 2019 | 53 | 1.250 |
Why?
|
Pneumococcal Vaccines | 11 | 2017 | 397 | 1.090 |
Why?
|
Enterocolitis, Pseudomembranous | 4 | 2015 | 264 | 1.030 |
Why?
|
Gram-Positive Bacterial Infections | 7 | 2013 | 343 | 1.030 |
Why?
|
Anti-Bacterial Agents | 24 | 2019 | 7407 | 0.980 |
Why?
|
Colon | 5 | 2022 | 1792 | 0.930 |
Why?
|
Carbapenems | 4 | 2017 | 123 | 0.910 |
Why?
|
Enterobacteriaceae | 4 | 2017 | 161 | 0.860 |
Why?
|
Population Surveillance | 15 | 2016 | 2598 | 0.830 |
Why?
|
Sepsis | 6 | 2016 | 2585 | 0.820 |
Why?
|
Urinary Tract Infections | 4 | 2022 | 802 | 0.810 |
Why?
|
Patients' Rooms | 5 | 2015 | 62 | 0.810 |
Why?
|
Community-Acquired Infections | 6 | 2013 | 469 | 0.780 |
Why?
|
Catheterization, Central Venous | 3 | 2015 | 527 | 0.770 |
Why?
|
Housekeeping, Hospital | 2 | 2013 | 17 | 0.750 |
Why?
|
Long-Term Care | 4 | 2019 | 633 | 0.730 |
Why?
|
Influenza, Human | 3 | 2019 | 1521 | 0.700 |
Why?
|
Patient Transfer | 6 | 2013 | 794 | 0.680 |
Why?
|
Hospitalization | 11 | 2019 | 10723 | 0.670 |
Why?
|
Digestive System Surgical Procedures | 4 | 2021 | 572 | 0.660 |
Why?
|
Disease Notification | 4 | 2013 | 95 | 0.650 |
Why?
|
Patient Readmission | 6 | 2015 | 3270 | 0.620 |
Why?
|
Nasal Cavity | 8 | 2014 | 304 | 0.620 |
Why?
|
Guideline Adherence | 5 | 2017 | 2220 | 0.610 |
Why?
|
Patient Isolation | 4 | 2015 | 100 | 0.600 |
Why?
|
Molecular Typing | 3 | 2013 | 116 | 0.590 |
Why?
|
Computer Simulation | 6 | 2016 | 6240 | 0.590 |
Why?
|
Prevalence | 21 | 2020 | 15732 | 0.580 |
Why?
|
Quality Indicators, Health Care | 4 | 2017 | 1792 | 0.520 |
Why?
|
Hysterectomy | 2 | 2018 | 857 | 0.510 |
Why?
|
Urinary Catheterization | 1 | 2016 | 193 | 0.500 |
Why?
|
Humans | 144 | 2022 | 761504 | 0.490 |
Why?
|
Vaccines, Conjugate | 4 | 2010 | 328 | 0.490 |
Why?
|
International Classification of Diseases | 5 | 2016 | 909 | 0.490 |
Why?
|
Diagnostic Tests, Routine | 4 | 2018 | 787 | 0.480 |
Why?
|
Environmental Microbiology | 2 | 2012 | 47 | 0.480 |
Why?
|
Personnel, Hospital | 2 | 2014 | 285 | 0.470 |
Why?
|
Pneumonia, Staphylococcal | 1 | 2014 | 39 | 0.470 |
Why?
|
Patient Discharge | 9 | 2015 | 3443 | 0.460 |
Why?
|
Acinetobacter Infections | 1 | 2014 | 73 | 0.460 |
Why?
|
Influenza Vaccines | 2 | 2019 | 768 | 0.460 |
Why?
|
Health Facilities | 3 | 2016 | 580 | 0.450 |
Why?
|
Contact Tracing | 2 | 2020 | 271 | 0.450 |
Why?
|
Patient Admission | 5 | 2015 | 1367 | 0.440 |
Why?
|
Occupational Health Services | 1 | 2014 | 150 | 0.440 |
Why?
|
Cluster Analysis | 13 | 2020 | 2707 | 0.440 |
Why?
|
Interinstitutional Relations | 2 | 2013 | 236 | 0.430 |
Why?
|
Meningococcal Vaccines | 4 | 2007 | 94 | 0.430 |
Why?
|
Hospital Shared Services | 1 | 2012 | 16 | 0.420 |
Why?
|
Computer Systems | 1 | 2014 | 470 | 0.420 |
Why?
|
Candidiasis | 1 | 2015 | 365 | 0.420 |
Why?
|
Sentinel Surveillance | 4 | 2015 | 291 | 0.420 |
Why?
|
Health Policy | 3 | 2016 | 2684 | 0.420 |
Why?
|
Retrospective Studies | 38 | 2022 | 80636 | 0.410 |
Why?
|
Disease Transmission, Infectious | 7 | 2019 | 559 | 0.410 |
Why?
|
Vaccination | 4 | 2014 | 3384 | 0.400 |
Why?
|
Medicare | 7 | 2021 | 6770 | 0.400 |
Why?
|
Microbial Sensitivity Tests | 8 | 2016 | 1937 | 0.400 |
Why?
|
Nasopharynx | 6 | 2012 | 401 | 0.390 |
Why?
|
Vancomycin | 3 | 2013 | 503 | 0.390 |
Why?
|
Health Facility Administration | 1 | 2011 | 29 | 0.390 |
Why?
|
Aged | 43 | 2021 | 169289 | 0.380 |
Why?
|
Aged, 80 and over | 26 | 2017 | 58976 | 0.380 |
Why?
|
Hospitals, County | 1 | 2011 | 17 | 0.380 |
Why?
|
Clinical Coding | 1 | 2012 | 181 | 0.370 |
Why?
|
Middle Aged | 44 | 2019 | 220895 | 0.370 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2012 | 130 | 0.370 |
Why?
|
Serotyping | 9 | 2012 | 325 | 0.360 |
Why?
|
Electronic Health Records | 5 | 2017 | 4811 | 0.360 |
Why?
|
Laparoscopy | 1 | 2022 | 2035 | 0.360 |
Why?
|
Arthroplasty, Replacement, Hip | 4 | 2017 | 1413 | 0.340 |
Why?
|
Male | 62 | 2019 | 360804 | 0.330 |
Why?
|
Clostridium Infections | 2 | 2018 | 558 | 0.330 |
Why?
|
Epidemiologic Methods | 2 | 2011 | 1336 | 0.320 |
Why?
|
Cost Savings | 1 | 2014 | 913 | 0.320 |
Why?
|
Female | 64 | 2019 | 392644 | 0.320 |
Why?
|
Comparative Effectiveness Research | 2 | 2013 | 709 | 0.320 |
Why?
|
Cohort Studies | 20 | 2018 | 41487 | 0.310 |
Why?
|
Administration, Intranasal | 3 | 2019 | 477 | 0.310 |
Why?
|
beta-Lactam Resistance | 4 | 2017 | 73 | 0.310 |
Why?
|
Coronary Artery Bypass | 3 | 2017 | 2188 | 0.310 |
Why?
|
Health Care Surveys | 3 | 2012 | 2426 | 0.310 |
Why?
|
Mandatory Programs | 3 | 2014 | 86 | 0.310 |
Why?
|
Child Day Care Centers | 2 | 2009 | 122 | 0.300 |
Why?
|
Documentation | 1 | 2014 | 897 | 0.300 |
Why?
|
Models, Economic | 2 | 2015 | 716 | 0.300 |
Why?
|
Organizational Policy | 3 | 2015 | 432 | 0.290 |
Why?
|
Adult | 36 | 2021 | 221177 | 0.280 |
Why?
|
Methicillin | 1 | 2006 | 62 | 0.280 |
Why?
|
Health Services | 1 | 2012 | 752 | 0.280 |
Why?
|
Universal Precautions | 1 | 2006 | 34 | 0.270 |
Why?
|
Length of Stay | 7 | 2015 | 6425 | 0.270 |
Why?
|
Hospital Costs | 4 | 2015 | 947 | 0.260 |
Why?
|
United States | 28 | 2021 | 72334 | 0.240 |
Why?
|
Academic Medical Centers | 7 | 2018 | 2759 | 0.240 |
Why?
|
Child, Preschool | 24 | 2017 | 42230 | 0.240 |
Why?
|
Software | 2 | 2010 | 4434 | 0.230 |
Why?
|
Inpatients | 2 | 2013 | 2548 | 0.230 |
Why?
|
Preventive Health Services | 1 | 2009 | 567 | 0.230 |
Why?
|
Comorbidity | 5 | 2019 | 10508 | 0.230 |
Why?
|
Insurance Claim Review | 4 | 2013 | 741 | 0.230 |
Why?
|
Delivery of Health Care | 5 | 2022 | 5336 | 0.230 |
Why?
|
Health Education | 2 | 2008 | 1052 | 0.220 |
Why?
|
Adolescent | 20 | 2017 | 88319 | 0.220 |
Why?
|
Massachusetts | 15 | 2017 | 8830 | 0.220 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2013 | 1393 | 0.220 |
Why?
|
Poverty | 1 | 2015 | 2698 | 0.220 |
Why?
|
Incidence | 15 | 2016 | 21353 | 0.220 |
Why?
|
Diagnosis-Related Groups | 2 | 2015 | 449 | 0.210 |
Why?
|
Gram-Negative Bacteria | 3 | 2012 | 272 | 0.210 |
Why?
|
Hospital Bed Capacity | 2 | 2015 | 206 | 0.210 |
Why?
|
Genetic Variation | 4 | 2017 | 6567 | 0.210 |
Why?
|
Health Personnel | 3 | 2016 | 3335 | 0.210 |
Why?
|
Respiratory Tract Infections | 2 | 2008 | 1010 | 0.200 |
Why?
|
Young Adult | 14 | 2017 | 59243 | 0.200 |
Why?
|
Risk Factors | 16 | 2018 | 74206 | 0.200 |
Why?
|
Polymerase Chain Reaction | 4 | 2016 | 6075 | 0.200 |
Why?
|
Bacterial Infections | 4 | 2015 | 1390 | 0.200 |
Why?
|
Nose | 4 | 2015 | 521 | 0.200 |
Why?
|
Infant | 18 | 2017 | 36192 | 0.200 |
Why?
|
Insurance, Health | 4 | 2015 | 2498 | 0.200 |
Why?
|
Health Care Costs | 2 | 2012 | 3242 | 0.190 |
Why?
|
Penicillin Resistance | 3 | 2009 | 74 | 0.190 |
Why?
|
Gram-Positive Bacteria | 1 | 2002 | 177 | 0.180 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 2 | 2012 | 142 | 0.180 |
Why?
|
Child | 25 | 2017 | 80153 | 0.180 |
Why?
|
Pneumonia, Ventilator-Associated | 2 | 2022 | 279 | 0.180 |
Why?
|
Molecular Epidemiology | 2 | 2013 | 469 | 0.180 |
Why?
|
Multivariate Analysis | 7 | 2013 | 12059 | 0.180 |
Why?
|
Medical Audit | 2 | 2012 | 453 | 0.180 |
Why?
|
beta-Lactamases | 3 | 2017 | 304 | 0.170 |
Why?
|
Models, Theoretical | 3 | 2016 | 3575 | 0.160 |
Why?
|
Prospective Studies | 10 | 2017 | 54425 | 0.160 |
Why?
|
Hygiene | 1 | 2019 | 94 | 0.160 |
Why?
|
Risk | 4 | 2011 | 9610 | 0.150 |
Why?
|
Time Factors | 8 | 2017 | 39967 | 0.150 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 3889 | 0.150 |
Why?
|
R Factors | 1 | 2017 | 35 | 0.140 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 1998 | 133 | 0.140 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7390 | 0.140 |
Why?
|
Odds Ratio | 4 | 2015 | 9646 | 0.140 |
Why?
|
Communicable Disease Control | 2 | 2016 | 846 | 0.140 |
Why?
|
Hospitals, Teaching | 2 | 2015 | 1156 | 0.130 |
Why?
|
Drug Utilization | 4 | 2012 | 1188 | 0.130 |
Why?
|
Hospitals, Community | 2 | 2016 | 365 | 0.130 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4740 | 0.130 |
Why?
|
Beds | 1 | 2016 | 47 | 0.130 |
Why?
|
Mass Screening | 4 | 2015 | 5428 | 0.130 |
Why?
|
Linear Models | 3 | 2016 | 5871 | 0.130 |
Why?
|
Pneumonia | 2 | 2008 | 2143 | 0.130 |
Why?
|
Clostridium | 1 | 2015 | 100 | 0.120 |
Why?
|
Bacteriuria | 1 | 2015 | 102 | 0.120 |
Why?
|
Time Management | 1 | 2015 | 52 | 0.120 |
Why?
|
Boston | 5 | 2017 | 9326 | 0.120 |
Why?
|
Forms and Records Control | 1 | 2015 | 158 | 0.120 |
Why?
|
Acinetobacter | 1 | 2014 | 39 | 0.120 |
Why?
|
Candida | 1 | 2015 | 172 | 0.120 |
Why?
|
Stochastic Processes | 1 | 2016 | 355 | 0.120 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1998 | 662 | 0.120 |
Why?
|
Residence Characteristics | 1 | 2004 | 2093 | 0.110 |
Why?
|
Staphylococcal Protein A | 1 | 2013 | 39 | 0.110 |
Why?
|
Interferon-alpha | 1 | 1998 | 921 | 0.110 |
Why?
|
Arthroplasty, Replacement | 1 | 2017 | 310 | 0.110 |
Why?
|
Klebsiella pneumoniae | 1 | 2015 | 250 | 0.110 |
Why?
|
Measles | 1 | 2015 | 183 | 0.110 |
Why?
|
Health Facility Size | 1 | 2013 | 61 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10209 | 0.110 |
Why?
|
Immunization | 1 | 2017 | 1228 | 0.110 |
Why?
|
Parents | 1 | 2007 | 3563 | 0.110 |
Why?
|
DNA Transposable Elements | 1 | 2017 | 755 | 0.110 |
Why?
|
Electronic Mail | 1 | 2014 | 213 | 0.110 |
Why?
|
Public Health | 2 | 2019 | 2669 | 0.100 |
Why?
|
Genes, Bacterial | 1 | 2016 | 1073 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2017 | 495 | 0.100 |
Why?
|
Mandatory Reporting | 1 | 2013 | 123 | 0.100 |
Why?
|
Escherichia coli Infections | 1 | 2016 | 518 | 0.100 |
Why?
|
Gases | 1 | 2013 | 204 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 4016 | 0.100 |
Why?
|
Otitis Media | 2 | 2012 | 286 | 0.100 |
Why?
|
Algorithms | 3 | 2016 | 14031 | 0.100 |
Why?
|
Age Distribution | 2 | 2012 | 2880 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2016 | 868 | 0.100 |
Why?
|
Anti-Infective Agents | 2 | 2016 | 983 | 0.100 |
Why?
|
Reminder Systems | 1 | 2014 | 388 | 0.090 |
Why?
|
Skilled Nursing Facilities | 1 | 2015 | 398 | 0.090 |
Why?
|
Logistic Models | 5 | 2017 | 13255 | 0.090 |
Why?
|
Insurance Claim Reporting | 1 | 2011 | 166 | 0.090 |
Why?
|
Opsonin Proteins | 1 | 2010 | 144 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2000 | 2049 | 0.090 |
Why?
|
Nasal Mucosa | 1 | 2013 | 416 | 0.090 |
Why?
|
Quality Control | 1 | 2013 | 832 | 0.090 |
Why?
|
Gastroenteritis | 1 | 2012 | 236 | 0.090 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2015 | 464 | 0.090 |
Why?
|
Fimbriae Proteins | 1 | 2010 | 132 | 0.080 |
Why?
|
Sex Factors | 3 | 2015 | 10552 | 0.080 |
Why?
|
Benchmarking | 2 | 2014 | 1045 | 0.080 |
Why?
|
Forecasting | 2 | 2016 | 2928 | 0.080 |
Why?
|
Hydrogen Peroxide | 1 | 2013 | 730 | 0.080 |
Why?
|
Genotype | 3 | 2013 | 12990 | 0.080 |
Why?
|
Research Design | 2 | 2017 | 6180 | 0.080 |
Why?
|
Feedback | 1 | 2013 | 791 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1126 | 0.080 |
Why?
|
Cross-Sectional Studies | 5 | 2016 | 26125 | 0.080 |
Why?
|
Immunization Programs | 1 | 2011 | 268 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2319 | 0.080 |
Why?
|
Checklist | 1 | 2015 | 827 | 0.080 |
Why?
|
Models, Biological | 1 | 2005 | 9469 | 0.080 |
Why?
|
Evaluation Studies as Topic | 1 | 2011 | 1624 | 0.080 |
Why?
|
Vascular Surgical Procedures | 2 | 2014 | 1489 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2013 | 1080 | 0.080 |
Why?
|
Policy | 1 | 2011 | 508 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39106 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2013 | 809 | 0.070 |
Why?
|
Thyrotropin-Releasing Hormone | 2 | 1998 | 139 | 0.070 |
Why?
|
Occupational Diseases | 1 | 2015 | 1490 | 0.070 |
Why?
|
Genetics, Population | 1 | 2012 | 937 | 0.070 |
Why?
|
Membrane Transport Proteins | 1 | 2012 | 1035 | 0.070 |
Why?
|
Communicable Diseases | 1 | 2015 | 875 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 7827 | 0.070 |
Why?
|
Age Factors | 3 | 2013 | 18395 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2013 | 1386 | 0.070 |
Why?
|
Environmental Monitoring | 1 | 2013 | 1460 | 0.070 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2008 | 238 | 0.070 |
Why?
|
Soft Tissue Infections | 1 | 2008 | 168 | 0.070 |
Why?
|
Phylogeny | 2 | 2016 | 2811 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2013 | 22176 | 0.060 |
Why?
|
Drug Resistance, Microbial | 1 | 2008 | 825 | 0.060 |
Why?
|
Risk Assessment | 6 | 2014 | 23995 | 0.060 |
Why?
|
Biomedical Research | 2 | 2017 | 3429 | 0.060 |
Why?
|
Antibodies, Bacterial | 1 | 2010 | 1469 | 0.060 |
Why?
|
Family Health | 1 | 2009 | 1257 | 0.060 |
Why?
|
Bacteria | 1 | 2015 | 2199 | 0.060 |
Why?
|
Escherichia coli | 1 | 2016 | 4217 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2000 | 4527 | 0.060 |
Why?
|
Monte Carlo Method | 1 | 2009 | 1258 | 0.060 |
Why?
|
Macrolides | 1 | 2004 | 205 | 0.050 |
Why?
|
Bacterial Proteins | 2 | 2017 | 3847 | 0.050 |
Why?
|
Data Collection | 1 | 2012 | 3322 | 0.050 |
Why?
|
Lung Diseases | 1 | 2013 | 1909 | 0.050 |
Why?
|
Oropharynx | 2 | 2015 | 138 | 0.050 |
Why?
|
Protein Precursors | 2 | 1998 | 1132 | 0.050 |
Why?
|
Outpatients | 1 | 2011 | 1597 | 0.050 |
Why?
|
Program Evaluation | 2 | 2010 | 2495 | 0.050 |
Why?
|
HIV-1 | 1 | 2000 | 6863 | 0.050 |
Why?
|
Critical Care | 1 | 2015 | 2696 | 0.050 |
Why?
|
San Francisco | 1 | 2002 | 162 | 0.050 |
Why?
|
Quality Improvement | 1 | 2017 | 3801 | 0.050 |
Why?
|
Sinusitis | 1 | 2011 | 991 | 0.050 |
Why?
|
Genome, Bacterial | 2 | 2017 | 783 | 0.050 |
Why?
|
Program Development | 1 | 2007 | 1297 | 0.050 |
Why?
|
Penicillins | 1 | 2004 | 402 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2015 | 20098 | 0.040 |
Why?
|
Medicaid | 1 | 2013 | 2818 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2007 | 1779 | 0.040 |
Why?
|
Databases, Factual | 1 | 2015 | 7967 | 0.040 |
Why?
|
Demography | 1 | 2004 | 1648 | 0.040 |
Why?
|
Drug Prescriptions | 2 | 2008 | 1670 | 0.040 |
Why?
|
Cost-Benefit Analysis | 3 | 2017 | 5492 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2013 | 4330 | 0.040 |
Why?
|
Rectum | 2 | 2013 | 892 | 0.040 |
Why?
|
Medical Records | 2 | 2014 | 1408 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14666 | 0.040 |
Why?
|
Transformation, Bacterial | 1 | 2017 | 76 | 0.040 |
Why?
|
United States Government Agencies | 1 | 2016 | 26 | 0.030 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2000 | 621 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2006 | 1421 | 0.030 |
Why?
|
Gene Flow | 1 | 2016 | 78 | 0.030 |
Why?
|
Societies, Scientific | 2 | 2007 | 222 | 0.030 |
Why?
|
Subtilisins | 1 | 1995 | 81 | 0.030 |
Why?
|
Gloves, Protective | 1 | 2015 | 23 | 0.030 |
Why?
|
Models, Statistical | 1 | 2010 | 5079 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5840 | 0.030 |
Why?
|
Culture Media | 2 | 2007 | 897 | 0.030 |
Why?
|
Academies and Institutes | 1 | 2017 | 318 | 0.030 |
Why?
|
Time | 1 | 2016 | 546 | 0.030 |
Why?
|
Current Procedural Terminology | 1 | 2015 | 89 | 0.030 |
Why?
|
Colony Count, Microbial | 1 | 2015 | 330 | 0.030 |
Why?
|
Suburethral Slings | 1 | 2015 | 72 | 0.030 |
Why?
|
Geography | 1 | 2016 | 656 | 0.030 |
Why?
|
Research Report | 1 | 2017 | 367 | 0.030 |
Why?
|
Administration, Topical | 1 | 2016 | 704 | 0.030 |
Why?
|
Laminectomy | 1 | 2015 | 225 | 0.030 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 1995 | 311 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 793 | 0.030 |
Why?
|
DNA, Bacterial | 2 | 2010 | 1479 | 0.030 |
Why?
|
HIV Infections | 1 | 2000 | 17351 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1659 | 0.030 |
Why?
|
Confidentiality | 1 | 2017 | 609 | 0.030 |
Why?
|
Bacterial Load | 1 | 2013 | 152 | 0.030 |
Why?
|
Masks | 1 | 2015 | 208 | 0.030 |
Why?
|
Pituitary Gland | 1 | 1995 | 635 | 0.030 |
Why?
|
Cholecystectomy | 1 | 2015 | 406 | 0.030 |
Why?
|
Advisory Committees | 2 | 2007 | 787 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2017 | 2180 | 0.030 |
Why?
|
Health Records, Personal | 1 | 2013 | 127 | 0.030 |
Why?
|
Antidiarrheals | 1 | 2012 | 46 | 0.020 |
Why?
|
Foodborne Diseases | 1 | 2012 | 41 | 0.020 |
Why?
|
Cryptosporidium | 1 | 2012 | 41 | 0.020 |
Why?
|
Bacteriological Techniques | 1 | 2013 | 275 | 0.020 |
Why?
|
Enterotoxins | 1 | 2013 | 367 | 0.020 |
Why?
|
Reference Values | 2 | 2010 | 4920 | 0.020 |
Why?
|
Salmonella | 1 | 2012 | 125 | 0.020 |
Why?
|
Appendectomy | 1 | 2015 | 433 | 0.020 |
Why?
|
Markov Chains | 1 | 2015 | 966 | 0.020 |
Why?
|
Comprehensive Health Care | 1 | 2012 | 123 | 0.020 |
Why?
|
Diarrhea | 1 | 2018 | 1318 | 0.020 |
Why?
|
Health Priorities | 1 | 2014 | 374 | 0.020 |
Why?
|
Multilocus Sequence Typing | 1 | 2011 | 100 | 0.020 |
Why?
|
Bacterial Typing Techniques | 1 | 2011 | 263 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 592 | 0.020 |
Why?
|
Recurrence | 1 | 2003 | 8465 | 0.020 |
Why?
|
Axilla | 1 | 2012 | 624 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2000 | 6310 | 0.020 |
Why?
|
Operon | 1 | 2010 | 372 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 2015 | 807 | 0.020 |
Why?
|
Heart Failure | 1 | 2013 | 11669 | 0.020 |
Why?
|
Acetylglucosamine | 1 | 2010 | 189 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1998 | 2161 | 0.020 |
Why?
|
Sampling Studies | 1 | 2010 | 615 | 0.020 |
Why?
|
Risk Adjustment | 1 | 2012 | 600 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1175 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6534 | 0.020 |
Why?
|
Reimbursement, Incentive | 1 | 2013 | 543 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2016 | 2330 | 0.020 |
Why?
|
Bacterial Toxins | 1 | 2013 | 931 | 0.020 |
Why?
|
International Cooperation | 1 | 2014 | 1422 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2691 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2000 | 3396 | 0.020 |
Why?
|
Illinois | 1 | 2007 | 120 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1505 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2169 | 0.020 |
Why?
|
Maryland | 1 | 2007 | 277 | 0.020 |
Why?
|
Research | 1 | 2014 | 1982 | 0.020 |
Why?
|
Survival Analysis | 1 | 1998 | 10090 | 0.020 |
Why?
|
Feces | 1 | 2012 | 1497 | 0.020 |
Why?
|
Antigens, Bacterial | 1 | 2010 | 1155 | 0.010 |
Why?
|
Societies, Medical | 2 | 2007 | 3905 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3092 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2010 | 64680 | 0.010 |
Why?
|
Decision Making | 1 | 2017 | 3929 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8631 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2477 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8654 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8002 | 0.010 |
Why?
|
Disease Progression | 1 | 1998 | 13506 | 0.010 |
Why?
|
Drug Resistance | 1 | 2006 | 1596 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2011 | 26198 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2012 | 2491 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8224 | 0.010 |
Why?
|
Managed Care Programs | 1 | 2004 | 940 | 0.010 |
Why?
|
Pituitary Gland, Anterior | 1 | 1998 | 142 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15266 | 0.010 |
Why?
|
Proprotein Convertase 2 | 1 | 1995 | 11 | 0.010 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 1995 | 65 | 0.010 |
Why?
|
Culture Techniques | 1 | 1995 | 531 | 0.010 |
Why?
|
Proprotein Convertases | 1 | 1995 | 95 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 14605 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9177 | 0.010 |
Why?
|
Molecular Weight | 1 | 1995 | 2186 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1995 | 754 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1998 | 2113 | 0.010 |
Why?
|
Dexamethasone | 1 | 1998 | 1948 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1995 | 2496 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1998 | 36426 | 0.010 |
Why?
|
Transfection | 1 | 1998 | 5774 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2008 | 15842 | 0.010 |
Why?
|
Cattle | 1 | 1995 | 3849 | 0.010 |
Why?
|
Animals | 3 | 2010 | 168459 | 0.000 |
Why?
|
Cell Membrane | 1 | 1995 | 3688 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1998 | 5112 | 0.000 |
Why?
|
Gene Expression | 1 | 1998 | 7581 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1998 | 7594 | 0.000 |
Why?
|
Cell Line | 1 | 1998 | 15601 | 0.000 |
Why?
|
Mice | 1 | 2010 | 81525 | 0.000 |
Why?
|
Rats | 1 | 1998 | 23742 | 0.000 |
Why?
|